Drug recall – irbesartan/hydrochlorothiazide

January 4, 2019

Actavis is recalling certain batches of irbesartan/hydrochlorothiazide tablets from pharmacies as a precautionary measure due to possible contamination with N-nitrosodiethylamine (NDEA).

For a detailed list of batches please see Irbesartan recall sheet

For more information please contact the pharmacy department on ext. 5259.